500万欧元门槛引爆中欧医疗器械贸易战，全球供应链加速重构

Group 1 - The European Commission has imposed a ban on Chinese medical device companies from participating in public tenders exceeding €5 million (approximately ¥40 million), which is expected to reshape the global medical device industry landscape [2][3] - The ban is part of a broader trade conflict centered around "fair competition," with the EU's investigation into China's procurement practices highlighting the requirement for a certain level of domestic production [3][4] - China's Ministry of Finance responded with a countermeasure, excluding EU companies from government procurement projects valued over ¥4.5 million, specifically targeting 50 types of medical devices imported from the EU [5][6] Group 2 - Despite the challenges posed by the EU's procurement barriers, the Chinese medical device industry still sees potential in overseas markets, particularly in regions with unmet medical needs such as Asia, Africa, and Latin America [6][7] - Companies are encouraged to adapt their strategies by collaborating with local firms and establishing overseas production bases to navigate trade barriers and maintain market presence [6][7] - The global medical device supply chain is undergoing rapid restructuring, indicating a shift in competitive dynamics as new markets emerge [7]